Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.
Loss
G E
GE
Department of Surgery, University of Chicago, IL 60637, USA.
Grewal
H P
HP
Siegel
C T
CT
Peace
D
D
Mead
J
J
Bruce
D S
DS
Cronin
D C
DC
Millis
J M
JM
Newell
K A
KA
Woodle
E S
ES
D000208:Acute Disease; D000328:Adult; D005260:Female; D006084:Graft Rejection / Q000473:pathology / Q000628:therapy*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D007683:Kidney Tubular Necrosis, Acute / Q000473:pathology; D008297:Male; D010956:Plasmapheresis; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D016559:Tacrolimus